Mr. Mohammad Rizki Fadhil Pratama
My Social Links

Mr. Mohammad Rizki Fadhil Pratama

Assistant Professor
Universitas Muhammadiyah Palangkaraya, Palangka Raya, Indonesia


Highest Degree
Ph.D. Student in Pharmacy and Pharmaceutical Technology from Universitas Airlangga, Indonesia

Share this Profile

Biography

Mohammad Rizki Fadhil Pratama is a lecturer at the Department of Pharmacy, Universitas Muhammadiyah Palangkaraya, Indonesia, as well as a doctoral student in Pharmaceutical Sciences, Universitas Airlangga, Indonesia. His research interest is the discovery of new medicinal compounds with lead compounds derived from medicinal plant metabolites from Indonesia, using medicinal chemistry and bioinformatics approaches. His dissertation research is on developing benzoyl pinostrobin derivatives from Boesenbergia pandurata as an anti-breast cancer, under Professor Dr. Siswandono and Hadi Poerwono Ph.D.'s supervision. He participates in various scientific associations such as the Indonesian Society for Cancer Chemoprevention and the Indonesian Pharmacists Association. In addition to the pharmaceutical science, he also plays an active role in the field of scientific publications by joining several organizations, such as the Indonesian Association of Scientific Journal Editors, Indonesian Journal Volunteer Association, Council of Asian Science Editors, Asian Council of Science Editors, and others. He currently serves as Editor-in-Chief of two international journals: Borneo Journal of Pharmacy and Journal of Molecular Docking. He also plays an active role as associate editor and reviewer of dozens of scientific journals from Indonesia and abroad.

Area of Interest:

Medicinal and Pharmaceutical Chemistry
100%
Medicinal Chemistry
62%
Molecular Docking
90%
Pharmaceutical Sciences
75%
Isolation from Medicinal Plant
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
39
Abstracts
6

Selected Publications

  1. Zinad, D., A. Mahal, G. Salman, O. Shareef and M. Pratama, 2022. Molecular docking and DFT study of synthesized oxazine derivatives. Egypt. J. Chem., 65: 231-240.
    CrossRef  |  Direct Link  |  
  2. Siswodihardjo, S., M.R.F. Pratama, E.N. Praditapuspa, D. Kesuma, H. Poerwono and T. Widiandani, 2022. Boesenbergia pandurata as an anti-breast cancer agent: Molecular docking and ADMET study. Lett. Drug Des. Discovery, 19: 606-626.
    CrossRef  |  Direct Link  |  
  3. Salman, G.A., D.S. Zinad, A. Mahal, M.R.F. Pratama, M. Duan, A. Alkhouri and A. Alamiery, 2022. Synthesis, antibacterial activity, and molecular docking study of bispyrazole‐based derivatives as potential antibacterial agents. ChemistrySelect, Vol. 7 10.1002/slct.202103901.
    CrossRef  |  Direct Link  |  
  4. Hasan, A.H., S. Murugesan, S.I. Amran, S. Chander and M.M. Alanazi et al., 2022. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation. Bioorg. Chem., Vol. 119. 10.1016/j.bioorg.2021.105572.
    CrossRef  |  Direct Link  |  
  5. Hasan, A.H., N.H. Hussen, S. Shakya, J. Jamalis and M.R.F. Pratama, 2022. In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions. Struct. Chem., 33: 1645-1665.
    CrossRef  |  Direct Link  |  
  6. Hasan, A.H., N.H. Hussen, S. Shakya, J. Jamalis and M.R.F. Pratama et al., 2022. Discovery of multitargeting inhibitors for the treatment of COVID19: An in-silico studies. Res. Square, 10.21203/rs.3.rs-1503192/v1.
    CrossRef  |  Direct Link  |  
  7. Ansori, A.N.M., V.D. Kharisma, A.A. Parikesit, F.A. Dian and M. Rebezov et al., 2022. Bioactive compounds from mangosteen (Garcinia mangostana L.) as an antiviral agent via dual inhibitor mechanism against SARSCoV- 2: An in silico approach. Pharm. J., 14: 85-90.
    CrossRef  |  Direct Link  |  
  8. Zinad, D.S., A. Mahal, A.M. A-Qader, S. Siswodihardjo, M.R.F. Pratama and R. Mohapatra, 2021. 3D-molecular modeling, antibacterial activity and molecular docking studies of some imidazole derivatives. Egypt. J. Chem., 64: 93-105.
    CrossRef  |  Direct Link  |  
  9. Pratama, M.R.F., T.A. Nasibova, D. Pratiwi, P. Kumar and E.A. Garaev, 2021. Peganum harmala and its alkaloids as dopamine receptor antagonists: In silico study. Biointerface Res. Appl. Chem., 11: 10301-10316.
    CrossRef  |  Direct Link  |  
  10. Pratama, M.R.F., H. Poerwono and S. Siswodihardjo, 2021. Introducing a two‐dimensional graph of docking score difference vs. similarity of ligand‐receptor interactions. Indonesian J. Biotechnol., 26: 54-60.
    CrossRef  |  Direct Link  |  
  11. Pratama, M.R.F., 2021. Comparison of language used for journal names indexed in SINTA ranked 1 and 2. Publ. Lett., 1: 1-5.
    CrossRef  |  Direct Link  |  
  12. Naspiah, N., M.R.F. Pratama and Sukardiman, 2021. Xanthine Oxidase Inhibition Activity and ADMET Properties of Terap (Artocarpus odoratissimus Blanco) Leaves Metabolites: Phytochemical Screening and in silico Studies. Pharm. J., 13: 1150-1160.
    CrossRef  |  Direct Link  |  
  13. Ekowati, J., R. Handayani, D.M. Hariyadi, M.R.F. Pratama and P.H. Khairunnisa et al., 2021. Pemberdayaan Masyarakat melalui Edukasi Cara Pembuatan Pangan Olahan yang Baik, Bahan Tambahan Pangan, dan Kemasan Pangan untuk Penguatan Jaminan Keamanan pada Pelaku UMKM Bidang Makanan di Balikpapan. Pengabdianmu J. Ilmiah Pengabdian Masyarakat, 6: 625-634.
    CrossRef  |  Direct Link  |  
  14. Mulyani, E., S. Suratno and M.R.F. Pratama, 2020. Formulasi dan evaluasi gel topikal antibakteri fraksi aktif akar kuning (Arcangelisia flava Merr.). J. Pharma Sci., 10.20527/jps.v7i1.8081.
    CrossRef  |  Direct Link  |  
  15. Kumar P., S. Singh and M.R.F. Pratama, 2020. Synthesis of some novel 1h-indole derivatives with antibacterial activity and antifungal activity. Letters in Applied NanoBioScience 9: 961-967.
    CrossRef  |  Direct Link  |  
  16. Suratno, S., E. Mulyani and M.R.F. Pratama, 2019. In-vitro study of antioxidant activities from ethanol extracts of akar kuning (Arcangelisia flava). J. Surya Medika, 4: 66-71.
    Direct Link  |  
  17. Nurbudiyani, I., S. Sonedi, E.S. Suyati and M.R.F. Pratama, 2019. Development of micro, small and medium enterprises rattan woven crafts in central kalimantan, Indonesia. Anterior J., 18: 132-142.
    Direct Link  |  
  18. Pratama, M.R.F., S. Suratno and E. Mulyani, 2018. Profile of thin-layer chromatography and UV-Vis spectrophotometry of akar kuning stem extract (Arcangelisia flava). Borneo J. Pharm., 1: 72-76.
    Direct Link  |  
  19. Pratama, M.R.F., S. Suratno and E. Mulyani, 2018. Antibacterial activity of akar kuning (Arcangelisia flava) secondary metabolites: Molecular docking approach. Asian J. Pharm. Clin. Res., 11: 447-451.
    Direct Link  |  
  20. Pratama, M.R.F. and Sutomo, 2018. Chemical structure optimization of lupeol as ER-α and HER2 inhibitor. Asian J. Pharm. Clin. Res., 11: 298-303.
    Direct Link  |  
  21. Pratama, M.R.F. and E. Suhartono, 2018. Understanding the interaction between glutathione and acetaminophen: A docking study approach. Dentino, 3: 215-219.
    Direct Link  |  
  22. Ardhany, S.D., W. Pandaran and M.R.F. Pratama, 2018. A profile of antihypertensive medicines in Mas Amsyar hospital Kasongan Katingan regency. Borneo J. Pharmacy, 1: 47-50.
    CrossRef  |  Direct Link  |  
  23. Pratama, M.R.F., 2017. Akar kuning (Arcangelisia flava) as neuraminidase inhibitor: molecular docking and pharmacophore optimization approach. Adv. Health Sci. Res., 6: 502-511.
  24. Pratama, M.R.F. and T. Gusdinar, 2017. Between artemisinin and derivatives with neuraminidase: A docking study insight. Asian J. Pharm. Clin. Res., 10: 304-308.
    Direct Link  |  
  25. Pratama, M.R.F. and G.S. Pratomo, 2017. Pharmacophore optimization of berberine as HER2 inhibitor. J. Farmasi Indonesia, 14: 109-117.
  26. Pratama, M.R.F., 2016. Study of molecular docking of quinoline derivative compounds against estrogen-A receptors. J. Surya Medika, 2: 1-7.
    CrossRef  |  Direct Link  |  
  27. Pratama, M.R.F., 2016. Molecular docking study of quinolin derivatives towards estrogen α receptor. Health Sci., .
  28. Pratama, M.R.F., 2016. Akar kuning (Arcangelisia flava) as EGFR inhibitor: In silico study. J. Farmagazine, 3: 6-16.
    Direct Link  |  
  29. Nurhayati, B., M.S. Wibowo, Y. Widyastuti, P.P. Erawijantari, W. Widowati, M.R.F. Pratama and T.G. Kartawinata, 2015. In silico analysis of plantaricin EF that expressed by plasmid-associated bacteriocin production gene of Lactobacillus plantarum IBL-2 for anti-candida agent potential. Res. J. Microbiol., 10: 582-591.
    CrossRef  |  Direct Link  |